We understand that registering for a conference is not essential right now and many researchers will be unable to register for a future conference of interest if their university or lab is temporarily closed. Therefore, you can simply register your interest here to be kept updated with details about this conference without committing to attending and our team will keep in touch with you regarding deadline reminders and grant opportunities. We hope this service is of use at this difficult time.
This conference is a continuation of the DNA Replication as a Source of DNA Damage series.
The maintenance of genome integrity is critical for the suppression of several pathological disorders in humans, including cancer, infertility and neurodegeneration. Moreover, the accumulation of unrepaired errors in DNA is commonly cited as a likely cause of tissue and organismal ageing. Destabilization of the genome can occur as a result of several cell intrinsic or extrinsic factors, including errors arising during DNA replication or chromosome segregation, as well as exposure of cells to agents that induce DNA damage. In this conference, we aim to bring together scientists studying DNA replication, DNA repair and chromosome segregation with those interested in how chromosomal instability can influence human pathology. Moreover, we aim to show how high throughput and high content screening methods can be used as a discovery tool both for basic science applications and to identify potential therapeutic modalities.
Take advantage of this fantastic opportunity for students! Fully paying academics can bring a student for only €820. Unfortunately, Postdocs are not eligible for this offer. Both registration packages include; accommodation for the 04, 05, 06 October 2021 (on a shared basis for students) and a food and beverage package for the conference period. Once registered, please contact Jack Peters to obtain a special registration link for your student.
Confirmed Invited Speakers
Monica Bettancour-Dias (Instituto Gulbenkian de Ciência)
María Blasco (Spanish National Cancer Research Center)
Thijn Brummelkamp (Netherlands Cancer Institute)
Keith Caldecott (University of Sussex)
Vincenzo Costanzo (IFOM)
Daniel Gerlich (Institute of Molecular Biotechnology)
Thanos Halazonetis (University of Geneva)
Steve Jackson (The Gurdon Institute)
Joanna Loizou (CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences)
Núria López-Bigas (IRB Barcelona)
Ana Losada (Spanish National Cancer Research Center)
Niels Mailand (Novo Nordisk Foundation Center for Protein Research)
Marcos Malumbres (Spanish National Cancer Research Center)
René Medema (Netherlands Cancer Institute)
Serena Nik-Zainal (MRC Cancer Unit)
Andre Nussenzweig (National Institutes of Health)
Ketan Patel (MRC LMB)
Christopher E. Pearson (The Hospital for Sick Children)
Zuzana Storchova (TU Kaiserslautern)
Steve West (Francis Crick Institute)
- Pathways for repair of DNA damage and disrupted DNA replication forks
- Screening tools for analysis of genome maintenance pathways and for development of new therapeutics
- Chromosome fragility caused by difficult-to-replicate loci – sources and roles of DNA repair proteins
- Chromosome instability as a driver of tumorigenesis, neurodegeneration and ageing
- Exploitation of defects in chromosome maintenance in cancer treatment
This meeting will appeal to Molecular/Cell Biologists/Geneticists & Biochemists interested in genome stability. Researchers interested in the molecular basis of cancer, neurodegenerative diseases and ageing and those with an interest in high throughput genetic and pharmacological screening methods will also find the conference highly relevant along with those wishing to exploit genome maintenance abnormalities in tumour cells for therapeutic benefit.
Chromosome instability is involved in several human diseases and is a feature of natural ageing. This conference will bridge fundamental studies on the mechanisms by which cells maintain genome stability with applications of these studies aimed at the development of new therapies. Hence, the conference will bridge basic biology and clinical applications in this rapidly advancing field. Attendees should be able to obtain a full picture of the current status of the field, as well as to interact with prominent research leaders driving the clinical application of the latest research.
If you're interested in sponsoring this conference please contact us.